A1M PHARMA
A1M Pharma alpha 1 microglobulin, a body protein that is of major importance for the body's defense against oxidative stress.
A1M PHARMA
Social Links:
Industry:
Health Care Medical Pharmaceutical
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.a1m.se
Status:
Active
Contact:
+46 46 286 50 30
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Wordpress Plugins
Similar Organizations
Double wood
Double wood is providing high-quality dietary supplements and keeping you in the know about industry-related news and research.
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
Official Site Inspections
http://www.a1m.se
- Host name: 192.36.52.200
- IP address: 192.36.52.200
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm

More informations about "A1M Pharma"
A1M Pharma - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +46 46 286 50 30 A1M Pharma alpha 1 microglobulin, a body protein that is of major importance for the body's defense against โฆSee details»
A1M Pharma - Overview, News & Similar companies | ZoomInfo.com
The company's Certified Advisor is Erik Penser Bank AB, tel. +46 (0)8-463 83 00, [email protected]. This constitutes information that A1M Pharma AB (publ) is โฆSee details»
A1M Pharma AB: Shareholders, Shareholding Structure
A1M Pharma AB is a Sweden-based company, which is active within the healthcare sector. The Company conducts development and commercialization of treatment and diagnostics based โฆSee details»
Company A1M Pharma AB Swiss Exchange - MarketScreener.com
A1M Pharma AB: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Swiss Exchange: | Swiss ExchangeSee details»
A1M Pharma - Products, Competitors, Financials, Employees, โฆ
A1M Pharma is a company focused on providing information about pharmaceuticals. Use the CB Insights Platform to explore A1M Pharma's full profile. Technology Vendors; Recent Research โฆSee details»
A1M Pharma AB - Life-Sciences-Europe.com
Sep 15, 2012 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl โ the European Association of Bioindustries ... A1M Pharma โฆSee details»
A1M Pharma AB: Contact Details and Business Profile
A1M Pharma develops a diagnostic method and treatment for pre-eclampsia, a condition that affects around 10 million pregnant women worldwide each year. This disorder is responsible โฆSee details»
A1M Pharma AB - life-sciences-europe.com
Upcoming Events. ChinaBio Partnering Forum 2023 Shanghai; BioSpain 2023 Barcelona; ILMAC 2023 Basel; BioCap Conference 2023 Alderley Park; BIO-Europe 2023 München (Munich)See details»
A1m Pharma AB - Overview, Competitors and Decision Makers โฆ
A1m Pharma ABis headquartered in Sweden, Lund - specialized in Biotechnology - Find employees, decision makers, competitors and company information. DataLead allows to โฆSee details»
A1M Pharma - VentureRadar
Guard Therapeutics (fka A1M Pharma) Sweden Publicly Traded Guard Therapeutics aims to develop and commercialize the lead drug candidate ROSgard, and thereby contribute to a โฆSee details»
A1M Pharma - Company Information, Competitors, News & FAQs
Find useful insights on A1M Pharma's company details, tech stack, news alerts, competitors and more. ... a1m.se. Type. N/A. A1M Pharma Technology Stack. Find prospects by the โฆSee details»
A1M Pharma - Guard Therapeutics
While A1M Pharma has struggled to find the optimal path forward for ROSgard over its long history, it now benefits from a clear story. Under new CEO Tobias Agervald and other new โฆSee details»
Articles about A1M Pharma - BioSpace
7 articles about A1M Pharma. A1M Pharma To Raise SEK 213 Million For Phase I/II ROSGard PPRT Kidney Damage Trials. 3/31/2017. A1M Pharma Has Successfully Conducted โฆSee details»
Governance A1M Pharma AB Nasdaq Stockholm
Find the composition of the Board of Directors of A1M Pharma AB (Nasdaq Stockholm Stock Exchange), the gender parity as well as the age distribution of the insiders.See details»
Nasdaq Stockholm Welcomes A1M Pharma to First North
Stockholm, June 20, 2017 โ Nasdaq (Nasdaq: NDAQ) announces that the trading in A1M Pharma ABโs shares (short name: A1M) commenced today on Nasdaq First North in โฆSee details»
Nasdaq Stockholm Welcomes A1M Pharma to First North
Jun 20, 2017 Founded in 2008 by researchers at Lund University, A1M Pharma is a biotechnology company that develops and commercializes medical applications based on the โฆSee details»
BioStock akademi case: A1M Pharma | Du har väl inte missat
Du har väl inte missat BioStockakademin? Utbildningsserien som fördjupar sig i Life Science och läkemedelsutveckling. Nytt fördjupningscase med A1M...See details»
A1M Pharma announces positive top-line results ... - Guard โฆ
A1M Pharma is listed on Nasdaq First North Growth Market Stockholm. The companyโs Certified Advisor is Erik Penser Bank AB, tel. +46 (0)8-463 83 00, [email protected] . This โฆSee details»
Green light for A1M Pharmaโs Phase I study - Nordic Life Science
Nov 12, 2018 The Swedish Medical Products Agency grants A1M Pharma permission to start a Phase I study with the drug candidate ROSgard. In the first part of the study, which is โฆSee details»
A1M Pharma : Swedish Medical Products Agency grants A1M โฆ
Nov 9, 2018 Read PDF A1M Pharma announces today that the Swedish Medical Products Agency has granted permission to start a clinical Phase I study of ROSgardโข - a drug โฆSee details»